Your browser is no longer supported. Please, upgrade your browser.
Settings
IDXX IDEXX Laboratories, Inc. daily Stock Chart
IDXX [NASD]
IDEXX Laboratories, Inc.
IndexS&P 500 P/E55.63 EPS (ttm)2.91 Insider Own1.30% Shs Outstand87.18M Perf Week1.17%
Market Cap14.13B Forward P/E45.78 EPS next Y3.54 Insider Trans-14.00% Shs Float86.00M Perf Month6.71%
Income263.20M PEG2.94 EPS next Q0.74 Inst Own92.40% Short Float2.85% Perf Quarter-1.39%
Sales1.86B P/S7.59 EPS this Y19.10% Inst Trans-0.89% Short Ratio4.30 Perf Half Y6.97%
Book/sh-0.98 P/B- EPS next Y11.53% ROA16.90% Target Price154.00 Perf Year47.98%
Cash/sh4.85 P/C33.42 EPS next 5Y18.90% ROE-492.10% 52W Range102.45 - 173.01 Perf YTD38.23%
Dividend- P/FCF51.82 EPS past 5Y11.90% ROI25.00% 52W High-6.66% Beta0.48
Dividend %- Quick Ratio0.70 Sales past 5Y7.80% Gross Margin55.80% 52W Low57.62% ATR2.65
Employees7365 Current Ratio0.90 Sales Q/Q9.10% Oper. Margin20.80% RSI (14)59.24 Volatility1.48% 1.68%
OptionableYes Debt/Eq- EPS Q/Q28.30% Profit Margin14.10% Rel Volume0.43 Prev Close162.10
ShortableYes LT Debt/Eq- EarningsAug 01 BMO Payout0.00% Avg Volume569.64K Price161.48
Recom2.10 SMA203.83% SMA502.04% SMA2008.32% Volume197,964 Change-0.38%
Aug-23-17Upgrade BofA/Merrill Neutral → Buy
Jul-28-17Upgrade CL King Neutral → Buy
Feb-03-17Downgrade Feltl & Co. Hold → Sell
Sep-29-16Resumed BofA/Merrill Neutral
Aug-16-16Reiterated Stifel Buy $120 → $125
Aug-03-16Upgrade Northcoast Sell → Neutral
Jul-20-16Reiterated Canaccord Genuity Buy $90 → $98
Apr-19-16Reiterated Canaccord Genuity Buy $80 → $85
Apr-01-16Initiated CL King Neutral
Mar-21-16Reiterated Stifel Buy $80 → $85
Feb-04-16Initiated Credit Suisse Outperform
Oct-29-15Reiterated Stifel Buy $85 → $80
Aug-28-15Downgrade Raymond James Outperform → Mkt Perform
Aug-13-15Reiterated Stifel Buy $78 → $85
Jul-23-15Reiterated Canaccord Genuity Buy $80 → $75
Apr-29-15Reiterated Stifel Buy $178 → $155
Jan-22-15Reiterated Canaccord Genuity Buy $160 → $175
Jan-16-15Reiterated Stifel Buy $155 → $178
Dec-10-14Reiterated Canaccord Genuity Buy $153 → $160
Oct-28-14Reiterated Canaccord Genuity Buy $139 → $153
Sep-19-17 09:56AM  Surmodics Receives FDA's Approval for PTA Balloon Catheter Zacks
08:58AM  Varian Medical (VAR) Releases FDA-Approved Eclipse 15.5 Zacks
08:57AM  Will Hurricanes Choke Cardiovascular (CSII) Q1 Performance? Zacks
08:55AM  Bruker (BRKR) Strong on Product Launches Amid Currency Woes Zacks
08:07AM  Masimo (MASI) Launches Rad-97 CO-Oximeter Post FDA Clearance Zacks
Sep-18-17 10:07AM  5 MedTech Stocks to Pick for Stellar Returns Zacks
08:30AM  McKesson to Gain From Distribution Business Amid Pricing Woes Zacks
08:06AM  Varian Conducts Clinical Workshop, Strengthens Algeria Hold Zacks
08:06AM  AngioDynamics' BioFlo Platform Strong, Debt Levels High Zacks
Sep-15-17 10:08AM  Phibro Animal Health Expands Globally Amid Tough Competition Zacks
09:57AM  Allscripts' Latest Initiative Eradicates Price Ambiguity Zacks
09:56AM  Thermo Fisher Fundamentals Impressive Amid Tough Competition Zacks
09:53AM  Surmodics Presents Encouraging SurVeil DCB Data at VIVA Meet Zacks
Sep-14-17 10:34AM  NuVasive Launches Breakthrough in MIS Surgery -- LessRay Zacks
10:31AM  Genomic Health Ties up With Biocartis, Boosts Oncotype DX Zacks
10:29AM  Here's Why Investors Should Buy Luminex (LMNX) Right Now Zacks
10:00AM  DaVita's (DVA) Green Initiatives Win a Coveted Golden Reward Zacks
09:38AM  Baxter (BAX) Hits a 52-Week High: What's Driving the Stock? Zacks
09:34AM  Amedisys Rides High on Strong Prospects Amid Margin Woes Zacks
Sep-13-17 10:03AM  IDEXX Laboratories Rides High on Strong CAG, Global Growth Zacks
Sep-12-17 10:45AM  Zacks.com featured highlights include Lululemon Athletica, Sanderson Farms, IDEXX Laboratories and NVR Zacks
10:06AM  IDEXX Laboratories, Inc. breached its 50 day moving average in a Bullish Manner : IDXX-US : September 12, 2017 Capital Cube
08:02AM  Cooper Companies Buys Teva's PARAGARD Intrauterine Platform Zacks
Sep-11-17 10:12AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
09:58AM  Ecolab (ECL) Features in DJSI List for Third Consecutive Year Zacks
09:32AM  Buy These 4 Efficient Stocks for Healthy Returns Zacks
09:31AM  5 Top-Ranked MedTech Growth Stocks for Solid Returns Zacks
Sep-08-17 09:04AM  Chemed Rides on VITAS Recovery, Robust Roto-Rooter Sales Zacks
08:51AM  Inogen (INGN) Hits a 52-Week High: What's Driving the Stock? Zacks
Sep-07-17 08:35AM  Cooper to Benefit From Specialty Lenses Prospects Amid Woes Zacks
Sep-06-17 04:30PM  IDEXX Laboratories to Present at Bank of America Merrill Lynch Global Healthcare Conference PR Newswire
12:30PM  Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead Zacks
10:55AM  Align Technology at 52-Week High: What's Driving the Stock? Zacks
10:43AM  Buy These 5 Large Caps on Extraordinary ROI Potential Zacks
09:50AM  Boston Scientific Grows on Innovation, Buyouts Amid Woes Zacks
09:10AM  HealthEquity (HQY) Q2 Earnings and Revenues Beat Estimates Zacks
08:05AM  Allscripts' (MDRX) dbMotion Platform Selected by SWSPHN Zacks
Sep-05-17 10:04AM  Henry Schein Joins IMF & LUGFA on Prostate Cancer Awareness Zacks
10:02AM  Quest Diagnostics (DGX) Banks on Buyouts, Competition Rife Zacks
09:58AM  Medtronic (MDT) & Mazor Robotics Tie-Up Reaches Next Level Zacks
09:51AM  Hologic (HOLX) Launches Brevera, Progresses in Breast Health Zacks
08:00AM  Brian McKeon Joins athenahealth Board of Directors GlobeNewswire
Sep-04-17 10:02AM  4 Large-Cap Medical Device Stocks to Buy Amid Political Woes Zacks
09:19AM  Mazor Robotics Hits 52-Week High Through Medtronic Alliance Zacks
07:54AM  GNC Holdings Gains on New GNC Strength Amid Soft Revenues Zacks
Sep-01-17 10:08AM  Haemonetics Grows on Strong Plasma, Blood Center Sluggish Zacks
09:22AM  Abbott's (ABT) FreeStyle Libre Gets Japan Reimbursement Nod Zacks
09:18AM  The Cooper Companies (COO) Beats Earnings Estimates in Q3 Zacks
08:32AM  Amedisys to Buy Intercity Home Care, Boosts Personal Care Arm Zacks
08:29AM  Abbott's AMPLATZER Pivotal Study to Strengthen Vascular Arm Zacks
05:35AM  BioScrip's Infusion Business Strong, Dull 2017 View a Drag (Revised) Zacks
Aug-31-17 10:33AM  Phibro Animal (PAHC) Beats Q4 Earnings & Sales Estimates Zacks
09:53AM  VWR Awaits Merger Closure, Stock Upside Potential Limited Zacks
08:56AM  Cooper (COO) Poised to Grow on Specialty Lenses Prospects Zacks
Aug-30-17 10:15AM  Thermo Fisher Acquires Patheon, Boosts Laboratory Products Zacks
10:13AM  Here's Why You Should Buy Lantheus Holdings (LNTH) Right Now Zacks
07:23AM  Intuitive Surgical (ISRG) Well Poised on Procedural Business Zacks
Aug-29-17 10:02AM  LabCorp Grows on Solid Diagnostics, Currency Woes a Drag Zacks
09:59AM  Medtronic (MDT) Sees a Mixed Q1, New Products Bode Well Zacks
09:57AM  PetMed Express Focuses on Advertising, Competition Rife Zacks
09:56AM  Henry Schein's Merritt Buyout to Boost U.S. Veterinary Arm Zacks
09:23AM  LabCorp & Interpace Extend Deal, Boost Cancer Portfolio Zacks
08:47AM  NxStage System One Gets FDA Nod for Solo Home Hemodialysis Zacks
08:44AM  Veeva (VEEV) to Gain Through Subscription Revenue Focus Zacks
Aug-28-17 10:11AM  Hill-Rom (HRC) Stock Down With Dull Patient Support Systems Zacks
09:25AM  LabCorp's $1.2 Billion Chiltern Buyout Gets FTC Approval Zacks
07:41AM  Express Scripts to Boost Oral Medication With Diabetes Study Zacks
Aug-25-17 04:35PM  IDEXX Laboratories (IDXX), Great Growth Pick: Here's Why Zacks
10:41AM  Luminex (LMNX) Banks on FDA Approvals & Portfolio Strength Zacks
10:20AM  Chemed (CHE) on Growth Track With VITAS & Roto-Rooter Arms Zacks
09:47AM  Illumina Teams Up With Telegraph Hill to Form Verogen Zacks
07:23AM  Veeva Systems (VEEV) Beats Q2 Earnings, Revenue Estimates Zacks
Aug-24-17 10:26AM  Align Technology-Patterson Dental Deal Expands iTero Reach Zacks
10:12AM  LabCorp to Add ChromaDex's Arm, Inorganic Expansion On Track Zacks
09:23AM  Stryker Recalls Sage Unit Products, Guidance Takes a Hit Zacks
09:17AM  IDEXX Labs Is 'Top Dog' Benzinga
09:06AM  Patterson Companies (PDCO) Beats on Q1 Earnings, Keeps View Zacks
08:59AM  Why IDEXX Laboratories (IDXX) Isn't Done Growing Earnings Yet Zacks
08:22AM  Civitas Solutions (CIVI) to Acquire Habilitative Services Zacks
Aug-23-17 09:52AM  Accuray (ARAY) Q4 Loss Wider Than Expected, Revenues Beat Zacks
09:50AM  Medtronic's (MDT) CE Mark in Heart Lead Strengthens CVG Arm Zacks
09:48AM  PerkinElmer Strong on Product Lineup Amid Integration Risks Zacks
Aug-22-17 05:00PM  Medtronic (MDT) Beats Q1 Earnings, Misses Revenue Estimates Zacks
09:54AM  PAREXEL Ties Up With Osaka International Cancer Institute Zacks
08:13AM  Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife Zacks
07:59AM  Quality Systems Professional Service a Drag, Competition Rife Zacks
Aug-21-17 11:09AM  Here's Why You Must Add Chemed (CHE) Stock to Your Portfolio Zacks
11:07AM  BioScrip's Infusion Business Strong, Dull 2017 View a Drag Zacks
Aug-18-17 11:02AM  Zimmer (ZBH) Plagued by Various Internal and External Issues Zacks
10:14AM  Myriad Genetics' EndoPredict Gets Positive Coverage Decision Zacks
10:11AM  Accuray's Radixact Now Used by Boise Summit Cancer Center Zacks
10:09AM  Globus Medical's Robotic Guidance System Gets FDA Approval Zacks
09:43AM  Walgreens Boots to Gain From Altered Rite Aid Deal, Alliance Zacks
Aug-17-17 09:31AM  Here's Why Investors Should Buy Edwards Lifesciences Now Zacks
09:25AM  Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now Zacks
12:15AM  Idexx Laboratories Inc (IDXX) Chairman, President & CEO Jonathan W Ayers Sold $9 million of ... GuruFocus.com
Aug-16-17 09:49AM  McKesson Banks on Distribution Business Amid Pricing Woes Zacks
09:43AM  BioTelemetry Hits a 52-Week High: What's Driving the Stock? Zacks
06:48AM  Invacare (IVC) Introduces TDX SP2 Power Wheelchair Globally Zacks
Aug-12-17 08:07AM  See what the IHS Markit Score report has to say about Idexx Laboratories Inc. Markit
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assays; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Studer JacquelineCVP, Gen. Counsel & SecretarySep 01Option Exercise0.001,12904,704Sep 06 06:06 PM
MAZELSKY JAYExecutive Vice PresidentSep 01Option Exercise0.002,366019,535Sep 06 06:05 PM
AYERS JONATHAN WChairman, President & CEOAug 28Option Exercise38.8016,000620,7201,044,034Aug 30 06:28 PM
AYERS JONATHAN WChairman, President & CEOAug 28Sale150.7913,0001,960,2641,031,034Aug 30 06:28 PM
HENDERSON REBECCA MDirectorAug 23Sale153.712,578396,26914,696Aug 25 05:01 PM
HENDERSON REBECCA MDirectorAug 22Sale152.862,578394,07317,274Aug 25 05:01 PM
AYERS JONATHAN WChairman, President & CEOAug 16Option Exercise38.8022,000853,4901,049,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 16Sale155.4720,0003,109,4881,029,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 15Option Exercise38.8022,000853,4901,041,934Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 15Sale154.6220,0003,092,3481,027,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 14Option Exercise38.8020,000775,9001,043,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 14Sale154.9118,0002,788,3371,025,034Aug 16 09:32 PM
AYERS JONATHAN WChairman, President & CEOAug 09Option Exercise38.8020,000775,9001,039,034Aug 10 08:20 PM
AYERS JONATHAN WChairman, President & CEOAug 09Sale154.5417,0002,627,1831,022,034Aug 10 08:20 PM
AYERS JONATHAN WChairman, President & CEOAug 08Option Exercise38.8020,000775,9001,038,034Aug 09 06:05 PM
AYERS JONATHAN WChairman, President & CEOAug 08Sale155.2218,0002,793,9601,020,034Aug 09 06:05 PM
Kingsley Lawrence DDirectorAug 03Buy151.762,000303,5173,344Aug 04 07:00 PM
TWIGGE GIOVANIChief Human Resources OfficerMay 31Sale166.902,572429,27216,332Jun 01 05:40 PM
AYERS JONATHAN WChairman, President & CEOMay 30Option Exercise38.8015,000581,9251,032,994Jun 01 05:40 PM
AYERS JONATHAN WChairman, President & CEOMay 30Sale167.8213,0002,181,6431,019,994Jun 01 05:40 PM
END WILLIAM TDirectorMay 22Sale162.555,000812,76945,256May 23 08:26 AM
AYERS JONATHAN WChairman, President & CEOMay 10Option Exercise38.8030,0001,163,8501,034,994May 11 06:01 PM
AYERS JONATHAN WChairman, President & CEOMay 10Sale162.6927,0004,392,6271,014,994May 11 06:01 PM
AYERS JONATHAN WChairman, President & CEOMay 05Option Exercise38.8030,0001,163,8501,040,994May 08 06:30 PM
AYERS JONATHAN WChairman, President & CEOMay 05Sale160.6126,0004,175,9381,014,994May 08 06:30 PM
HENDERSON REBECCA MDirectorMay 04Option Exercise38.806,602256,12521,552May 05 06:11 PM
HENDERSON REBECCA MDirectorMay 04Sale159.951,700271,91219,852May 05 06:11 PM
Kingsley Lawrence DDirectorMar 01Buy146.481,000146,4801,135Mar 02 06:01 PM
HENDERSON REBECCA MDirectorFeb 28Sale145.196,500943,72114,950Mar 06 06:44 PM
AYERS JONATHAN WChairman, President & CEOFeb 22Option Exercise39.0152,2862,039,6711,045,947Feb 23 06:12 PM
AYERS JONATHAN WChairman, President & CEOFeb 22Sale142.5835,0004,990,1351,010,947Feb 23 06:12 PM
MCKEON BRIAN PExecutive VP & CFOFeb 16Option Exercise53.191,88099,98838,548Feb 21 05:45 PM
END WILLIAM TDirectorFeb 16Sale141.715,000708,53450,256Feb 21 05:45 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTFeb 14Option Exercise0.001,703019,432Feb 16 07:23 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryFeb 14Option Exercise0.0075203,769Feb 16 07:22 PM
MAZELSKY JAYExecutive Vice PresidentFeb 14Option Exercise0.002,157017,802Feb 16 07:21 PM
MCKEON BRIAN PExecutive VP & CFOFeb 14Option Exercise0.002,166037,477Feb 16 07:20 PM
AYERS JONATHAN WChairman, President & CEOFeb 14Option Exercise0.006,3340996,820Feb 16 07:20 PM
END WILLIAM TDirectorFeb 10Option Exercise38.806,602256,12555,256Feb 14 05:27 PM
JUNIUS DANIEL MDirectorFeb 08Option Exercise64.693,000194,0705,495Feb 09 05:20 PM
AYERS JONATHAN WChairman, President & CEOFeb 08Option Exercise26.6636,250966,2441,026,736Feb 09 05:21 PM
MCKEON BRIAN PExecutive VP & CFOFeb 08Option Exercise26.669,924264,52445,235Feb 09 05:21 PM
AYERS JONATHAN WChairman, President & CEOFeb 08Sale141.6336,2505,134,171990,486Feb 09 05:21 PM
MCKEON BRIAN PExecutive VP & CFOFeb 08Sale141.649,9241,405,59135,311Feb 09 05:21 PM
JUNIUS DANIEL MDirectorFeb 08Sale141.753,000425,2642,495Feb 09 05:20 PM
MCKEON BRIAN PExecutive VP & CFOJan 01Option Exercise0.002,820036,416Jan 04 06:00 PM
MAZELSKY JAYExecutive Vice PresidentDec 05Option Exercise0.00962015,904Dec 07 04:15 PM
Studer JacquelineCVP, Gen. Counsel & SecretaryNov 30Option Exercise79.5480063,6322,974Dec 02 05:26 PM
AYERS JONATHAN WChairman, President & CEONov 29Option Exercise38.8014,236552,2861,004,667Nov 30 07:40 PM
AYERS JONATHAN WChairman, President & CEONov 29Sale119.9714,2361,707,839990,431Nov 30 07:40 PM
AYERS JONATHAN WChairman, President & CEONov 28Option Exercise38.8015,764611,5641,001,043Nov 30 07:40 PM
AYERS JONATHAN WChairman, President & CEONov 28Sale119.5713,1881,576,859987,855Nov 30 07:40 PM
CRAIG THOMASDirectorNov 23Option Exercise26.669,924264,52432,783Nov 28 07:33 PM
CRAIG THOMASDirectorNov 23Sale120.068,5001,020,51924,283Nov 28 07:33 PM
MAZELSKY JAYExecutive Vice PresidentNov 18Option Exercise47.532,204104,75614,942Nov 21 07:33 PM
AYERS JONATHAN WChairman, President & CEONov 09Option Exercise26.6640,0001,066,2001,027,855Nov 10 05:02 PM
AYERS JONATHAN WChairman, President & CEONov 09Sale107.8540,0004,314,187987,855Nov 10 05:02 PM
END WILLIAM TDirectorNov 08Sale109.875,000549,35948,654Nov 09 05:35 PM